Mankind Pharma unveils mucormycosis drug POSAFORCE
10 June 2021 | News
The company has received DCGI approval recently
Image Credit: shutterstock.com
Mankind Pharma has launched Posaconazole Gastro - Resistant tablets with the brand name POSAFORCE 100. The drug is used to treat mucormycosis.
Recently Posaconazole has also been approved by the Drug Controller General of India (DCGI).
In addition, guidelines from AIIMS and ICMR have also recommended the use of Posaconazole as an effective option for the management of mucormycosis. Posaconazole is US FDA approved anti-fungal drug with minimal potential for nephrotoxicity and an excellent tolerability profile.
According to a statement issued by Mankind Pharma the product has been launched under POSACONAZOLE 100 tablets to fight against this infection. Mankind always strive to launch affordable medicines with an endeavour to achieve the best quality standards in the pharmaceutical industry.
